3,293 results on '"Takahashi, Koichi"'
Search Results
202. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)
203. Novel tablet formulation of amorphous indomethacin using wet granulation with a high-speed mixer granulator combined with porous calcium silicate
204. Down-regulation of EZH2 expression in myelodysplastic syndromes
205. Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients
206. Similarities and Contrasts in the Archaeal Community of Two Japanese Mountains : Mt. Norikura Compared to Mt. Fuji
207. Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHVand without TP53aberrations
208. Function Map-Driven Development for AGI
209. Fungal Elevational Rapoport pattern from a High Mountain in Japan
210. Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
211. Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases
212. Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
213. Outcomes of patients with therapy‐related myeloid neoplasms after treatment with poly( ADP ‐ribose) polymerase proteins inhibitors for solid tumours
214. transomics2cytoscape: An automated software for interpretable 2.5-dimensional visualization of trans-omic networks
215. Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
216. Autonomous calibration of pipetting for a human-robot collaborative environment
217. 3232 – TARGETING SOD1 INDUCES SYNTHETIC LETHAL KILLING OF PPM1D-MUTANT LEUKEMIA CELLS
218. The discovery of 3,3-dimethyl-1,2,3,4-tetrahydroquinoxaline-1-carboxamides as AMPD2 inhibitors with a novel mechanism of action
219. Stochastic processes dominate soil arbuscular mycorrhizal fungal community assembly along an elevation gradient in central Japan
220. 高炉羽口におけるラジカル化学発光測定を活用した微粉炭燃焼率推定手法の開発
221. 台風19号時の高波浪による湯河原海岸の急激な侵食とその後の砂浜回復
222. Segmentation-free Direct Iris Localization Networks
223. Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes
224. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases
225. Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluridine Using Human Small Intestinal Epithelial Cells
226. Complete atomistic model of a bacterial cytoplasm for integrating physics, biochemistry, and systems biology
227. Neurophysiological basis of creativity in healthy elderly people: A multiscale entropy approach
228. Characteristics and Outcomes of Patients With Multiple Myeloma Who Develop Therapy-Related Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
229. Pressure-drop Reduction and Heat-transfer Deterioration of Slush Nitrogen in Square Pipe flow
230. Pressure Drop and Heat Transfer Characteristics of Boiling Nitrogen in Square Pipe flow
231. New Unsteady Axisymmetric Vortex Solutions and Their Sensitivity to Boundary Conditions
232. Foundations of E-Cell Simulation Environment Architecture
233. Clonal hematopoiesis and solid tumor risk: New insights from the Women's Health Initiative.
234. Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
235. RAS Pathway Mutations Are Associated with Progression after Hypomethylating Agent Therapy in Chronic Myelomonocytic Leukemia
236. Preclinical Efficacy of Novel Drug Combination Against AML with 3q26 Lesions and EVI1 Overexpression
237. Clinical and Molecular Characterization of Newly Diagnosed IDH/TP53 Co-Mutated AML and Impact of Genomically Sensitive Treatment Strategies
238. Genome-Wide CRISPR Screen Reveals Dependency of PPM1D-mutant Cells on DNA Repair
239. Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): 4-Year Follow-up Data
240. A Phase I/II Study of Combination of Azacitidine, Venetoclax and Pevonedistat in Patients with Newly-Diagnosed Secondary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Hypomethylating Agent (HMA) Failure
241. Clinical and Biological Effects of Canakinumab in Lower-Risk Myelodysplastic Syndromes (MDS): Results from a Phase 2 Clinical Trial
242. Efficacy of Novel Non-Chemotherapy Combinations Against AML Cells with Mutant NPM1
243. Efficacy of Vcp/p97 Inhibitor, CB-5339, Alone and in Combinations Against High-Risk AML, Including Those with Genetic Lesion in TP53
244. The Adverse Effect of Myelodysplasia-Related Mutations in De Novo Acute Myeloid Leukemia Is Associated with Higher Variant Allelic Frequency (VAF): A Proposal for a Numeric Cutoff for Variant Allelic Frequency
245. Short Telomere Syndromes and Inherited Predisposition to Bone Marrow Diseases: The MDACC Experience
246. Long-Term Follow-up of Low-Dose Dasatinib (50mg Daily) As Frontline Therapy in Newly Diagnosed Chronic Myeloid Leukemia
247. Venetoclax Added to Cladribine (CLAD) + Low Dose AraC (LDAC) Alternating with Azacitidine (AZA) Is Highly Active As Frontline Therapy in Older Patients with Newly Diagnosed Acute Myeloid Leukemia in a Phase 2 Study
248. A Phase II Study of Azacitidine Plus Venetoclax As Maintenance Therapy in Acute Myeloid Leukemia: Durable Responses with Longer Term Follow-up
249. Phase Ib/2 Study of Oral Decitabine/Cedazuridine (ASTX727) and Venetoclax in Combination with the Targeted Mutant IDH1 Inhibitor Ivosidenib or the Targeted Mutant IDH2 Inhibitor Enasidenib in IDH Mutated Acute Myeloid Leukemia
250. Outcomes of Older Patients with Aplastic Anemia Treated with Frontline Anti-Thymocyte Globulin (ATG)-Based Immunosuppressive Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.